查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504940

癌症惡病質市場、佔有率、規模、趨勢、產業分析報告：按療法、作用機制、通路、地區、細分市場預測，2024-2032年

Cancer Cachexia Market Share, Size, Trends, Industry Analysis Report, By Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到2032年，全球癌症惡病質市場規模預計將達到 34.3 億美元。本報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

癌症盛行率的急劇增加，尤其是在老年族群中，以及醫療保健專業人員對惡病質重要性的認識不斷提高，都有助於全球市場的成長。隨著癌症患者數量的增加，個體罹患癌症惡病質的風險也隨之增加。

例如，根據 GLOBOCAN2022 資料，到2022年，超過 53%的癌症患者年齡將超過 65 歲。隨著世界老化人口迅速增加，預計到2022年將增加到 7.6 億，到2050年將增加到 16 億，癌症的盛行率也可能很高。

越來越多的政府措施支持癌症研究並促進先進治療和藥物的市場發展也支持了市場成長。有一些大型製藥公司參與開發專門用於解決癌症惡病質的新療法。

例如，2023年 8月，Actimed Therapeutics 宣布籌集了 475 萬英鎊，用於治療癌症惡病質和許多其他肌肉萎縮疾病。這筆資金將用於繼續公司的發展並確保其 IMPACT 臨床開發計劃做好準備。

癌症是40歲至79歲族群的第一大死因，80%的癌症患者與惡病質有關，約20%的患者死於癌症惡病質。非常需要對這種複雜的病症進行進一步研究，並開發針對與惡病質相關的特定分子途徑的標靶治療。

例如，2023年9月，Actimed Therapeutics宣布其S-pindolol Benzate（一種治療非小細胞肺癌患者惡病質的藥物）的2B/3期臨床試驗IND申請已獲得FDA批准美國FDA。

癌症惡病質市場報告亮點

2023年，黃體素藥物因其高治療效率和抗發炎作用而佔有顯著佔有率。

食慾刺激劑細分市場在2023年佔據了大部分佔有率，這歸因於癌症患者廣泛採用來保持體形和體質。

由於線上藥局具有處方管理和節省時間等功能，因此越來越受歡迎，被歸類為通路的線上藥局細分市場預計在預測期內將以最高的年複合成長率成長。

北美因其完善的醫療基礎設施和高癌症盛行率而在全球市場佔據主導地位。

主要市場參與者包括 Aeterna Zentaris、ANI Pharmaceuticals、Merck &Co.Inc.、TCI Peptide Therapeutics 和 Teva Pharmaceutical Industries。

目錄

第1章 簡介

  • 報告摘要
    • 研究目的
    • 市場範圍
    • 先決條件
  • 利害關係人

第2章 執行摘要

第3章 研究方法

第4章 全球癌症惡病質市場洞察

  • 分銷通路快照
  • 癌症惡病質市場動態
    • 推動因素和機會
      • 癌症惡病質盛行率的增加推動了全球市場的成長
      • 研發活動投資的增加推動市場成長
    • 抑制因素和挑戰
      • 治療成本高、監管嚴格
  • PESTEL 分析
  • 癌症惡病質市場的通路趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球癌症惡病質市場：依治療分類

  • 主要發現
  • 簡介
  • 黃體素
  • 皮質類固醇
  • 合併治療
  • 其他

第6章 全球癌症惡病質市場：依作用機制

  • 主要發現
  • 簡介
  • 食慾刺激劑
  • 體重穩定劑

第7章 全球癌症惡病質市場：依通路劃分

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第8章 全球癌症惡病質市場：依地區

  • 主要發現
  • 簡介
    • 癌症惡病質市場評估：依地區劃分，2019-2032年
  • 北美
    • 北美：依治療分類，2019-2032年
    • 北美：依通路劃分，2019-2032年
    • 北美：依作用機制劃分，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依療法分類，2019-2032年
    • 歐洲：依通路劃分，2019-2032年
    • 歐洲：依作用機制劃分，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依療法分類，2019-2032年
    • 亞太地區：依通路劃分，2019-2032年
    • 亞太地區：依作用機制劃分，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東和非洲：依療法分類，2019-2032年
    • 中東與非洲：依通路劃分，2019-2032年
    • 中東與非洲：依作用機制劃分，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依療法分類，2019-2032年
    • 拉丁美洲：依通路劃分，2019-2032年
    • 拉丁美洲：依作用機制劃分，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章 公司簡介

  • AbbVie Inc.（US）
  • Actimed Therapeutics（UK）
  • Aeterna Zentaris Inc.（Canada）
  • ANI Pharmaceuticals Inc.（US）
  • Aphios Corporation（US）
  • Aveo Pharmaceuticals Inc.（US）
  • Bristol-Myers Squibb Company（US）
  • Helsinn Group（Switzerland）
  • Hikma Pharmaceuticals PLC（UK）
  • Merck & Co. Inc.（US）
  • Mylan N.V.（US）
  • Pfizer Inc.（US）
  • TCI Peptide Therapeutics（US）
  • Teva Pharmaceutical Industries Ltd.（Israel）
Product Code: PM4913

The global cancer cachexia market size is expected to reach USD 3.43 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Cachexia Market Share, Size, Trends, Industry Analysis Report, By Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The drastic increase in the prevalence of cancer, especially among the geriatric population, and growing awareness among healthcare professionals about the significance of cachexia contribute to the global market growth. With the increase in cancer patients, the risk of developing cancer cachexia among individuals also rises.

For instance, according to the GLOBOCAN 2022 data, more than 53% of people who had cancer in 2022 were aged 65 years or above. As the world's ageing population is growing rapidly, with 760 million people in 2022, and is expected to rise to 1.6 billion people by 2050, the prevalence of cancer is also likely to increase.

A growing number of government initiatives supporting cancer research and promoting the development of advanced therapies and drugs also propelled the market's growth. There are key pharmaceutical companies involved in the development of new novel therapies that are specifically developed for addressing cancer cachexia.

For instance, in August 2023, Actimed Therapeutics, announced that they have raised £4.75 million for the treatment of cancer cachexia and many other muscle wasting disorders. The fund will be utilized to continue the development of the company and ensure the preparation of the IMPACT clinical development program.

Cancer remains the leading cause of death for people between the ages of 40-79 years old, and 80% of cancer cases are associated with cachexia, and approx. 20% of patients die due to cancer cachexia; there is a significant need for further studies regarding its complex condition and the development of targeted therapies that are aimed at the specific molecular pathways associated with cachexia.

For instance, in September 2023, Actimed Therapeutics, announced that they have received approval from US FDA for their IND application for Phase 2b/3 clinical study of the S-pindolol benzoate for the treatment of cachexia that are associated with patients with non-small cell lung cancer.

Cancer Cachexia Market Report Highlights

The Progestogens segment accounted for a notable share in 2023, on account of its greater efficiency in treatment and the presence of anti-inflammatory properties.

Appetite stimulators segment held the majority share in 2023, which is attributed to its widespread adoption by cancer patients for maintaining body shape and mass.

The online pharmacy segment categorized under the distribution channel is predicted to grow at the highest CAGR during the forecast period due to the growing popularity of online pharmacies due to its features like prescription management and time-saving.

North America dominated the global market, owing to the presence of well-established healthcare infrastructure and the significant prevalence of cancer.

The key market players include Aeterna Zentaris, ANI Pharmaceuticals, Merck & Co. Inc., TCI Peptide Therapeutics, and Teva Pharmaceutical Industries.

Polaris Market Research has segmented the cancer cachexia market report based on therapeutics, mechanism of action, distribution channel, and region:

Cancer Cachexia, Therapeutics Outlook (Revenue - USD Billion, 2024 - 2032)

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others

Cancer Cachexia, Mechanism of Action Outlook (Revenue - USD Billion, 2024 - 2032)

  • Appetite Stimulators
  • Weight Loss Stabilizers

Cancer Cachexia, Distribution Channel Outlook (Revenue - USD Billion, 2024 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Cancer Cachexia, Regional Outlook (Revenue - USD Billion, 2024 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East and Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Cachexia Market Insights

  • 4.1. Cancer Cachexia Market - Distribution Channel Snapshot
  • 4.2. Cancer Cachexia Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cancer cachexia cases to drive global market growth
      • 4.2.1.2. Rising investments in R&D activities spurring market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs and stringent regulations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Cachexia Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Cachexia Market, by Therapeutics

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • 5.3. Progestogens
    • 5.3.1. Global Cancer Cachexia Market, by Progestogens, by Region, 2019-2032 (USD Billion)
  • 5.4. Corticosteroids
    • 5.4.1. Global Cancer Cachexia Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 5.5. Combination Therapy
    • 5.5.1. Global Cancer Cachexia Market, by Combination Therapy, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Cancer Cachexia Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Cachexia Market, by Mechanism of Action

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 6.3. Appetite Stimulators
    • 6.3.1. Global Cancer Cachexia Market, by Appetite Stimulators, by Region, 2019-2032 (USD Billion)
  • 6.4. Weight Loss Stabilizers
    • 6.4.1. Global Cancer Cachexia Market, by Weight Loss Stabilizers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Cachexia Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Cancer Cachexia Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Cancer Cachexia Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Cancer Cachexia Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Cancer Cachexia Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Cachexia Market - North America
    • 8.3.1. North America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Cachexia Market - U.S.
      • 8.3.4.1. U.S.: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Cachexia Market - Canada
      • 8.3.5.1. Canada: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.4. Cancer Cachexia Market - Europe
    • 8.4.1. Europe: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Cachexia Market - UK
      • 8.4.4.1. UK: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Cachexia Market - France
      • 8.4.5.1. France: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Cachexia Market - Germany
      • 8.4.6.1. Germany: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Cachexia Market - Italy
      • 8.4.7.1. Italy: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Cachexia Market - Spain
      • 8.4.8.1. Spain: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Cachexia Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Cachexia Market - Russia
      • 8.4.10.1. Russia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.5. Cancer Cachexia Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Cachexia Market - China
      • 8.5.4.1. China: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Cachexia Market - India
      • 8.5.5.1. India: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Cachexia Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Cachexia Market - Japan
      • 8.5.7.1. Japan: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Cachexia Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Cachexia Market - South Korea
      • 8.5.9.1. South Korea: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.6. Cancer Cachexia Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Cachexia Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Cachexia Market - UAE
      • 8.6.5.1. UAE: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Cachexia Market - Israel
      • 8.6.6.1. Israel: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Cachexia Market - South Africa
      • 8.6.7.1. South Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.7. Cancer Cachexia Market - Latin America
    • 8.7.1. Latin America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Cachexia Market - Mexico
      • 8.7.4.1. Mexico: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Cachexia Market - Brazil
      • 8.7.5.1. Brazil: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Cachexia Market - Argentina
      • 8.7.6.1. Argentina: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc. (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Actimed Therapeutics (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3.Aeterna Zentaris Inc. (Canada)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. ANI Pharmaceuticals Inc. (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aphios Corporation (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Aveo Pharmaceuticals Inc. (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bristol-Myers Squibb Company (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Helsinn Group (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hikma Pharmaceuticals PLC (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck & Co. Inc. (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mylan N.V. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Pfizer Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. TCI Peptide Therapeutics (US)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceutical Industries Ltd. (Israel)
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables

  • Table 1 Global Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 12 Canada: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 13 Canada: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 15 Europe: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 16 Europe: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 18 UK: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 19 UK: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 21 France: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 22 France: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 24 Germany: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 25 Germany: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 27 Italy: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 28 Italy: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 30 Spain: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 31 Spain: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 36 Russia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 37 Russia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 42 China: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 43 China: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 45 India: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 46 India: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 51 Japan: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 52 Japan: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 66 UAE: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 67 UAE: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 69 Israel: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 70 Israel: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Cachexia Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Mechanism of Action
  • Figure 7. Global Cancer Cachexia Market, by Mechanism of Action, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Therapeutics
  • Figure 9. Global Cancer Cachexia Market, by Therapeutics, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Cancer Cachexia Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cancer Cachexia Market